ENTITY
Ajanta Pharma

Ajanta Pharma (AJP IN)

46
Analysis
Health Care • India
Ajanta Pharma is an Indian multinational pharmaceutical company that develops, manufactures, and markets specialty pharmaceutical finished dosages and branded generics. The company focuses on various therapeutic areas including cardiology, dermatology, ophthalmology, and pain management. It operates in India, the US, and over 30 emerging markets across Africa and Asia. Headquartered in Mumbai, India, the company was established in 1973.
more
•01 Mar 2015 23:26

India's Budgets: 2006-2015. Key Charts, and Key questions

In continuation of my work of detailed work on India Budget for last ten years, this piece through simple charts puts in perspective:  2014 Actual...

Share
•23 Jan 2026 14:43

Indian QSR Consolidation: A Rare Cash Arbitrage Play In RBA?

​Inspira Global acquires controlling stake in Restaurant Brands Asia at INR 70/share, offering investors an 8.36% arbitrage spread over 3-4 months...

Logo
306 Views
Share
bullish•Meesho
•31 Dec 2025 06:20

AMFI Stock Reclassification Preview (Dec 2025): New Listings and REIT Inclusion Drive Changes

36 stocks could see size reclassification in Jan. 12 new stocks could be added to Large and Mid-cap. REITs will be added to the AMFI classification...

Logo
668 Views
Share
bullish•Tata Capital
•20 Nov 2025 09:56

AMFI Stock Reclassification Preview (Dec 2025): New Listings Shaking Up the Rankings

We currently forecast 31 migrations for the AMFI December reclassification. Many IPOs could be added to Large/Mid cap. The forecast upward...

Logo
884 Views
Share
•03 Nov 2024 22:29

Ipca Laboratories (IPCA IN): Domestic Revenue Drives Q1FY25 Result; Full-Year Margin Guidance Raise

Ipca will announce Q2FY25 result on November 14. Thus far, Indian pharma companies have reported strong domestic revenue. We are expecting similar...

Logo
867 Views
Share
x